← Back to patent-cliff list
CAS 1632400-63-5
N-[3-(Benzylsulfanyl)propanoyl]-O-ethyl-D-tyrosyl-L-isoleucyl-O-benzyl-L-threonyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-N5-[(benzyloxy)carbonyl]-L-ornithylglycinamide
Codes: Atosiban-045
Application context (from source-drug indications)
产科分娩（早产）Atosiban acetate早产（孕37周前）Atosiban acetateEndometriosisAtosiban acetate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Atosiban acetate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N-[3-(Benzylsulfanyl)propanoyl]-O-ethyl-D-tyrosyl-L-isoleucyl-O-benzyl-L-threonyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-N5-[(benzyloxy)carbonyl]-L-ornithylglycinamide→N5-[(Benzyloxy)carbonyl]-L-ornithylglycinamide hydrochloride→N-[3-(Benzylsulfanyl)propanoyl]-O-ethyl-D-tyrosyl-L-isoleucyl-O-benzyl-L-threonyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-proline
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.